Free Trial
OTCMKTS:AOLS

Aeolus Pharmaceuticals (AOLS) Stock Price, News & Analysis

$0.0001 0.00 (0.00%)
As of 09:30 AM Eastern

About Aeolus Pharmaceuticals Stock (OTCMKTS:AOLS)

Advanced

Key Stats

Today's Range
$0.0001
$0.0001
50-Day Range
N/A
52-Week Range
$0.0001
$0.0050
Volume
10,000 shs
Average Volume
41,840 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AOLS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aeolus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AOLS Stock News Headlines

AOLS Aeolus Pharmaceuticals, Inc.
SDCI.P:CA St. Davids Capital Inc.
Gold surges past $3,600 … but this has beat gold by 1,000x
Gold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real opportunity isn’t in coins or bullion. In every major gold rally of the past 50 years, there’s been another investment that has delivered dramatically higher returns.tc pixel
ASLN ASLAN Pharmaceuticals Limited
Aeolus Tyre Co Ltd (600469)
Aeolus: Wind-mapping space laser is losing power
Aeolus Pharmaceuticals Inc
See More Headlines

AOLS Stock Analysis - Frequently Asked Questions

Aeolus Pharmaceuticals' stock was trading at $0.0003 at the beginning of 2025. Since then, AOLS shares have decreased by 66.7% and is now trading at $0.0001.

Aeolus Pharmaceuticals Inc. (OTCMKTS:AOLS) released its quarterly earnings results on Monday, August, 14th. The biopharmaceutical company reported ($0.01) earnings per share for the quarter. The biopharmaceutical company had revenue of $0.01 million for the quarter.

Shares of AOLS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Aeolus Pharmaceuticals investors own include Myriad Genetics (MYGN), Nutra Pharma (NPHC), Synergy Pharmaceuticals (SGYP), Titan Pharmaceuticals (TTNP), ADOMANI (ADOM), Agritek (AGTK) and

Company Calendar

Last Earnings
8/14/2017
Today
10/07/2025
Fiscal Year End
9/30/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:AOLS
CIK
1261734
Employees
4
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
1.37
10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (OTCMKTS:AOLS) was last updated on 10/7/2025 by MarketBeat.com Staff
From Our Partners